G20 won't include in communique need to resist protectionism - Nikkei

OSAKA (Reuters) - Group of 20 leaders will forgo including in its communique a phrase calling for the need to resist protectionism when they conclude their two-day meeting in Osaka, western Japan, on Saturday, the Nikkei newspaper reported. Instead, the G20 heads are seeking to reach an agreement to mention in the communique the importance of promoting a free, fair and non-discriminatory trade system, the economic daily reported on Saturday

Reuters June 29, 2019 06:05:56 IST
G20 won't include in communique need to resist protectionism - Nikkei

G20 wont include in communique need to resist protectionism  Nikkei

OSAKA (Reuters) - Group of 20 leaders will forgo including in its communique a phrase calling for the need to resist protectionism when they conclude their two-day meeting in Osaka, western Japan, on Saturday, the Nikkei newspaper reported.

Instead, the G20 heads are seeking to reach an agreement to mention in the communique the importance of promoting a free, fair and non-discriminatory trade system, the economic daily reported on Saturday.

(Reporting by Leika Kihara; Editing by Chang-Ran Kim)

This story has not been edited by Firstpost staff and is generated by auto-feed.

Updated Date:

TAGS:

Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.

also read

Gilead nears deal to buy Immunomedics for more than $20 billion, WSJ reports
Business

Gilead nears deal to buy Immunomedics for more than $20 billion, WSJ reports

(Reuters) - Gilead Sciences Inc is nearing a deal to buy biopharmaceutical company Immunomedics Inc for more than $20 billion, the Wall Street Journal reported on Saturday, citing people familiar with the matter. A deal for Immunomedics, which last month reported positive data from a late-stage study for its breast-cancer drug, could be announced Monday if not sooner, the Journal said https://www.wsj.com/articles/gilead-nears-deal-to-buy-immunomedics-for-more-than-20-billion-11599936777?mod=hp_lead_pos2. Gilead and Immunomedics did not respond immediately to emailed requests from Reuters for comment

China bans German pork imports after African swine fever case
Business

China bans German pork imports after African swine fever case

SHANGHAI (Reuters) - China banned pork imports from Germany on Saturday after it confirmed its first case of African swine fever last week, in a move set to hit German producers and push up global prices as China's meat supplies tighten. China's ban on imports from its third largest supplier comes as the world's top meat buyer deals with an unprecedented pork shortage after its own epidemic of the deadly hog disease. The ban on Germany, which has supplied about 14% of China's pork imports so far this year, will push up demand for meat from other major suppliers like the United States and Spain, boosting global prices.

Libya's Haftar committed to ending oil blockade, U.S. says
Business

Libya's Haftar committed to ending oil blockade, U.S. says

CAIRO (Reuters) - Libyan commander Khalifa Haftar has committed to ending a months-long blockade of oil facilities, the U.S.